Selectis Health, Inc.
GBCS
$3.10
$0.134.38%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 7.29M | 9.67M | 10.84M | 10.44M | 10.49M |
| Total Revenue | 7.29M | 9.67M | 10.84M | 10.44M | 10.49M |
| Cost of Revenue | 6.07M | 7.00M | 8.52M | 8.16M | 8.08M |
| Gross Profit | 1.22M | 2.67M | 2.32M | 2.29M | 2.41M |
| SG&A Expenses | 2.15M | 2.68M | 2.25M | 2.37M | 2.46M |
| Depreciation & Amortization | 333.20K | 384.00K | 364.70K | 362.70K | 363.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.55M | 10.07M | 11.14M | 10.89M | 10.91M |
| Operating Income | -1.26M | -395.70K | -297.00K | -450.30K | -421.70K |
| Income Before Tax | 6.94M | -803.30K | 752.40K | -308.00K | -656.00K |
| Income Tax Expenses | 409.70K | 800.00 | -- | -- | -- |
| Earnings from Continuing Operations | 6.53M | -804.10K | 752.40K | -308.00K | -656.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.53M | -804.10K | 752.40K | -308.00K | -656.00K |
| EBIT | -1.26M | -395.70K | -297.00K | -450.30K | -421.70K |
| EBITDA | -929.30K | -11.70K | 67.70K | -87.50K | -58.70K |
| EPS Basic | 2.13 | -0.26 | 0.24 | -0.10 | -0.22 |
| Normalized Basic EPS | -0.40 | -0.15 | 0.02 | -0.13 | -0.13 |
| EPS Diluted | 1.90 | -0.26 | 0.24 | -0.10 | -0.22 |
| Normalized Diluted EPS | -0.36 | -0.15 | 0.02 | -0.13 | -0.13 |
| Average Basic Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M | 3.07M |
| Average Diluted Shares Outstanding | 3.44M | 3.07M | 3.07M | 3.07M | 3.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -0.12% | -- | -- | -- |